Alkaloid delta Agonist BW373U86 Increases Hypoxic Tolerance
Authors:
- Daphne M. BofetiadoDBDaphne M. Bofetiado
- Kimberly P. MayfieldKMKimberly P. Mayfield
- Louis G. DʼalecyLDLouis G. Dʼalecy
- 1 June 1996
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 82 (6) , 1237-1241
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- 7-Benzylidenenaltrexone (BNTX): A selective δ1 opioid receptor antagonist in the mouse spinal cordLife Sciences, 1993
- A highly selective δ1-opioid receptor antagonist: 7-benzylidenenaltrexoneEuropean Journal of Pharmacology, 1992
- Role of endogenous opioid peptides in the acute adaptation to hypoxiaBrain Research, 1992
- Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).The Journal of Pharmacology and Experimental Therapeutics, 1992
- Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.The Journal of Pharmacology and Experimental Therapeutics, 1991
- Hypoxia-induced increases in hypoxic tolerance augmented by beta-hydroxybutyrate in mice.Stroke, 1989
- Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonistsLife Sciences, 1987
- Central nervous system hypoxia in children due to near drowning.Radiology, 1985
- The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexoneEuropean Journal of Pharmacology, 1981
- The Future of Clinical ResearchNew England Journal of Medicine, 1979